Samuel Coenen

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. doi request reprint Infectious diseases in primary care; managing the interface between the person and the community
    Samuel Coenen
    Centre for General Practice and Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Belgium
    Eur J Gen Pract 18:117-21. 2012
  2. pmc Antibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribing
    Samuel Coenen
    Centre for General Practice, University of Antwerp UIA, Antwerp, Belgium
    BMC Fam Pract 3:16. 2002
  3. ncbi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe
    Samuel Coenen
    Department of General Practice, University of Antwerp Antwerp, Belgium
    J Antimicrob Chemother 58:418-22. 2006
  4. pmc Antibiotic prescribing for acute cough: the effect of perceived patient demand
    Samuel Coenen
    Fund for Scientific Research, Flanders, Belgium
    Br J Gen Pract 56:183-90. 2006
  5. pmc European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe
    Samuel Coenen
    University of Antwerp Campus Drie Eiken, Department of General Practice, Universiteitsplein 1, 2610 Antwerp, Belgium
    Qual Saf Health Care 16:440-5. 2007
  6. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe
    Samuel Coenen
    Department of General Practice, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 64:200-5. 2009
  7. ncbi request reprint Management of acute cough: comparisons between Belgian and Dutch GPs
    Samuel Coenen
    Centre for General Practice, University of Antwerp, BE 2610 Antwerp, Belgium
    Eur J Gen Pract 10:152-6. 2004
  8. ncbi request reprint Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial
    Samuel Coenen
    Centre for General Practice, University of Antwerp, BE 2610 Antwerp, Belgium
    J Antimicrob Chemother 54:661-72. 2004
  9. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009)
    Samuel Coenen
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi57-70. 2011
  10. ncbi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe
    Samuel Coenen
    Department of General Practice, University of Antwerp Antwerp, Belgium
    J Antimicrob Chemother 58:413-7. 2006

Detail Information

Publications44

  1. doi request reprint Infectious diseases in primary care; managing the interface between the person and the community
    Samuel Coenen
    Centre for General Practice and Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Belgium
    Eur J Gen Pract 18:117-21. 2012
    ....
  2. pmc Antibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribing
    Samuel Coenen
    Centre for General Practice, University of Antwerp UIA, Antwerp, Belgium
    BMC Fam Pract 3:16. 2002
    ..We aimed to determine items of importance for the antibiotic prescribing decision and to make them operational for an intervention trial...
  3. ncbi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe
    Samuel Coenen
    Department of General Practice, University of Antwerp Antwerp, Belgium
    J Antimicrob Chemother 58:418-22. 2006
    ..Data on outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe were collected from 25 countries within the ESAC project, funded by DG SANCO of the European Commission, using the WHO ATC/DDD methodology...
  4. pmc Antibiotic prescribing for acute cough: the effect of perceived patient demand
    Samuel Coenen
    Fund for Scientific Research, Flanders, Belgium
    Br J Gen Pract 56:183-90. 2006
    ..GPs decide whether or not to prescribe antibiotics for acute cough. Apart from clinical signs and symptoms, non-medical reasons influence this decision as well...
  5. pmc European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe
    Samuel Coenen
    University of Antwerp Campus Drie Eiken, Department of General Practice, Universiteitsplein 1, 2610 Antwerp, Belgium
    Qual Saf Health Care 16:440-5. 2007
    ....
  6. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe
    Samuel Coenen
    Department of General Practice, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 64:200-5. 2009
    ..To assess the proportion of parenteral treatment of the total outpatient antibiotic use in Europe, and to identify the antibiotic groups and individual antibiotics most commonly administered in this way...
  7. ncbi request reprint Management of acute cough: comparisons between Belgian and Dutch GPs
    Samuel Coenen
    Centre for General Practice, University of Antwerp, BE 2610 Antwerp, Belgium
    Eur J Gen Pract 10:152-6. 2004
    ..We aimed to compare the management of acute cough between Belgian and Dutch general practitioners (GPs)...
  8. ncbi request reprint Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial
    Samuel Coenen
    Centre for General Practice, University of Antwerp, BE 2610 Antwerp, Belgium
    J Antimicrob Chemother 54:661-72. 2004
    ..To assess the effect of a tailored professional intervention, including academic detailing, on antibiotic prescribing for acute cough...
  9. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009)
    Samuel Coenen
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi57-70. 2011
    ....
  10. ncbi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe
    Samuel Coenen
    Department of General Practice, University of Antwerp Antwerp, Belgium
    J Antimicrob Chemother 58:413-7. 2006
    ..Data on outpatient cephalosporin use in Europe were collected from 25 countries within the ESAC project, funded by DG SANCO of the European Commission, using the WHO ATC/DDD methodology...
  11. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi3-12. 2011
    ..To describe total outpatient systemic antibiotic use in Europe from 1997 to 2009 and to analyse statistically trends of total use and composition of use over time...
  12. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi37-45. 2011
    ....
  13. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi47-56. 2011
    ....
  14. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009)
    Ann Versporten
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi25-35. 2011
    ....
  15. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009)
    Ann Versporten
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi13-23. 2011
    ..Data on 13 years (1997-2009) of outpatient penicillin use were collected from 33 European countries within the European Surveillance of Antimicrobial Consumption (ESAC) project and analysed in detail...
  16. ncbi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe
    Matus Ferech
    Laboratory of Microbiology, Department of General Practice, University of Antwerp Antwerp, Belgium
    J Antimicrob Chemother 58:401-7. 2006
    ..Data on outpatient antibiotic use were collected from 34 countries using the ATC/DDD methodology...
  17. ncbi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe
    Matus Ferech
    Laboratory of Microbiology, University of Antwerp Antwerp, Belgium
    J Antimicrob Chemother 58:423-7. 2006
    ..Data on outpatient quinolone use in Europe were collected from 25 countries within the ESAC project, funded by DG SANCO of the European Commission, using the WHO ATC/DDD methodology...
  18. pmc The effect of giving influenza vaccination to general practitioners: a controlled trial [NCT00221676]
    Barbara Michiels
    Department of Family Medicine, Centre for General Practice, University of Antwerp, University of Antwerp Campus Drie Eiken, Universiteitsplein 1, 2610 Antwerp, Belgium
    BMC Med 4:17. 2006
    ....
  19. ncbi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe
    Matus Ferech
    Laboratory of Microbiology, University of Antwerp Antwerp, Belgium
    J Antimicrob Chemother 58:408-12. 2006
    ..Data on outpatient penicillin use in Europe were collected from 25 countries within the ESAC project, funded by DG SANCO of the European Commission, using the WHO ATC/DDD methodology...
  20. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    J Antimicrob Chemother 65:769-74. 2010
    ..To assess the total outpatient systemic antimycotic and antifungal use in Europe, and to identify the antimycotic and antifungal substances most commonly used...
  21. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi71-77. 2011
    ..To assess quality of outpatient antibiotic use in Europe in 2009 based on the 12 European Surveillance of Antimicrobial Consumption (ESAC) drug-specific quality indicators and to evaluate changes in quality between 2004 and 2009...
  22. ncbi request reprint Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries
    Herman Goossens
    University of Antwerp, Antwerp, Belgium
    Clin Infect Dis 44:1091-5. 2007
    ....
  23. doi request reprint Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents
    Karolien Van Puyenbroeck
    Department of Primary and Interdisciplinary Care, University of Antwerp, Antwerp, Belgium
    Am J Clin Nutr 95:1165-71. 2012
    ..Age is associated with immune dysregulation, which results in an increased infection rate and reduced effectiveness of vaccination...
  24. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:1897-905. 2011
    ..To assess the total systemic antiviral use in Europe and to identify the antiviral substances most commonly used...
  25. doi request reprint Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures
    Samuel Coenen
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 69:529-34. 2014
    ..g. the number of defined daily doses (DDDs) or packages per 1000 inhabitants per day, producing conflicting findings. Therefore, we set out to explore what measure is most appropriate...
  26. pmc Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium
    Liesbet Van Heirstraeten
    University of Antwerp, Antwerp, Belgium
    Emerg Infect Dis 18:1515-8. 2012
    ..Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs...
  27. ncbi request reprint Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study
    Surbhi Malhotra-Kumar
    Department of Medical Microbiology, University of Antwerp, Belgium
    Lancet 369:482-90. 2007
    ..We used the macrolides azithromycin and clarithromycin to investigate the direct effect of antibiotic exposure on resistance in the oral streptococcal flora of healthy volunteers...
  28. pmc The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews
    Barbara Michiels
    Department of Primary and Interdisciplinary Care Antwerp, Centre for General Practice, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
    PLoS ONE 8:e60348. 2013
    ..No relevant benefits of these NIs on complications in at-risk individuals have been established...
  29. ncbi request reprint Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003)
    Barbara Michiels
    Centre for General Practice, University of Antwerp Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk Antwerpen, Belgium
    Vaccine 24:3145-52. 2006
    ..Besides vaccination, the (high) basic antibody titre before vaccination and working in a child and family preventive medicine unit were predicting a protective antibody level in GPs...
  30. doi request reprint β-blockers modify the prognostic value of adiponectin in chronic heart failure
    An M Van Berendoncks
    Department of Cardiology, Antwerp University Hospital, Edegem, Belgium
    Int J Cardiol 150:296-300. 2011
    ..We aimed to assess the prognostic importance of adiponectin in CHF towards heart failure-related hospital admissions and mortality, in relation to other clinical, laboratory and exercise data...
  31. doi request reprint Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight
    Niels Adriaenssens
    University of Antwerp, Vaccine and Infectious Disease Institute VAXINFECTIO, Laboratory of Medical Microbiology, Universiteitsplein 1, 2610 Antwerp, Belgium University of Antwerp, Vaccine and Infectious Disease Institute VAXINFECTIO, Centre for General Practice, Antwerp, Belgium Electronic address
    Int J Antimicrob Agents 42:466-70. 2013
    ..High use of fluconazole in PID might be more relevant for surveillance of antimicrobial consumption in relation to resistance than high use of terbinafine in DID. ..
  32. pmc Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough
    Samuel Coenen
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium Centre for General Practice, Department of Primary and Interdisciplinary Care Antwerp, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
    PLoS ONE 8:e76691. 2013
    ..Clinicians may not accurately identify those patients...
  33. pmc General practitioners' views on the acceptability and applicability of a web-based intervention to reduce antibiotic prescribing for acute cough in multiple European countries: a qualitative study prior to a randomised trial
    Sibyl Anthierens
    Centre for General Practice, Vaccine and Infectious Disease Institute VAXINFECTIO, Laboratory of Microbiology, University of Antwerp, Antwerp, Belgium
    BMC Fam Pract 13:101. 2012
    ..We explored GPs' views on the initial version of INTRO to test acceptability and potentially increase applicability for use in multiple countries before the start of a randomised trial...
  34. pmc Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional study
    Barbara Michiels
    Department of Primary and Interdisciplinary Care, Centre for General Practice, University of Antwerp, Belgium
    BMC Fam Pract 12:4. 2011
    ..Our objective is to formulate prediction rules for the diagnosis of influenza with the best diagnostic performance, combining symptoms, signs and context among patients with influenza-like illness...
  35. doi request reprint Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: a nationwide prescription-level analysis
    Adriaan Blommaert
    Centre for Health Economic Research and Modelling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 68:2383-92. 2013
    ..Therefore, we documented prescriber and patient characteristics associated with the choice between amoxicillin and broader-spectrum alternatives (co-amoxiclav or moxifloxacin) in recent years in Belgium...
  36. doi request reprint A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups
    Barbara Michiels
    Department of Primary and Interdisciplinary Care, Centre for General Practice, Faculty of Medicine, University of Antwerp, Universiteitsplein 1, B 2610 Antwerp, Belgium
    Vaccine 29:9159-70. 2011
    ....
  37. doi request reprint Implementation of e-Bug in Belgium
    Niels Adriaenssens
    University of Antwerp, Vaccine and Infectious Disease Institute VAXINFECTIO, Laboratory of Medical Microbiology, Antwerp, Belgium
    J Antimicrob Chemother 66:v51-3. 2011
    ..We also describe the impact of the organization of education in Belgium on the implementation process, as well as plans for the future of e-Bug in our country...
  38. doi request reprint Empowering patients or general practitioners? A randomised clinical trial to improve quality in reproductive health care in Belgium
    Lieve Peremans
    Department of Primary and Interdisciplinary Care, Faculty of Medicine, University of Antwerp, Antwerp Wilrijk, Belgium
    Eur J Contracept Reprod Health Care 15:280-9. 2010
    ..Evidence-based clinical guidelines on contraceptive use were developed and distributed among all Flemish general practitioners (GPs) in Belgium...
  39. pmc Patients' views on respiratory tract symptoms and antibiotics
    Huug van Duijn
    Br J Gen Pract 53:491-2. 2003
  40. ncbi request reprint Preferred antibiotics, dosages and length of treatments in general practice--a comparison between ten European countries
    Samuel Coenen
    Eur J Gen Pract 10:166-8. 2004
  41. ncbi request reprint Variation in outpatient antibiotic use in three European countries: exploration of possible determinants
    Huug J van Duijn
    Eur J Gen Pract 11:139-40. 2005
  42. ncbi request reprint Treating patients not diagnoses: challenging assumptions underlying the investigation and management of LRTI in general practice
    Rogier M Hopstaken
    Maastricht University, Care and Public Health Research Institute, Department of General Practice, PO Box 616, 6200 MD Maastricht, The Netherlands
    J Antimicrob Chemother 56:941-3. 2005
    ..The necessity of antibiotic treatment is largely unknown and rarely challenged...
  43. ncbi request reprint Comment on: Can mass media campaigns change antimicrobial prescribing? A regional evaluation study
    Samuel Coenen
    J Antimicrob Chemother 60:179-80. 2007
  44. pmc Antibiotics for respiratory tract infections in primary care
    Samuel Coenen
    BMJ 335:946-7. 2007